Currently, there are 328.44M common shares owned by the public and among those 321.57M shares have been available to trade.
The company’s stock has a 5-day price change of 44.15% and 48.45% over the past three months. BILI shares are trading 88.33% year to date (YTD), with the 12-month market performance up to 69.15% higher. It has a 12-month low price of $8.80 and touched a high of $21.62 over the same period. BILI has an average intraday trading volume of 5.68 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 45.52%, 52.54%, and 74.44% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Bilibili Inc ADR (NASDAQ: BILI) shares accounts for 22.76% of the company’s 328.44M shares outstanding.
It has a market capitalization of $7.37B and a beta (3y monthly) value of 0.84. The earnings-per-share (ttm) stands at -$1.34. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.84% over the week and 4.09% over the month.
Earnings per share for the fiscal year are expected to increase by 96.02%, and 1216.32% over the next financial year.
Looking at the support for the BILI, a number of firms have released research notes about the stock. Goldman stated their Buy rating for the stock in a research note on September 26, 2024, with the firm’s price target at $16.50-$22.60. Morgan Stanley coverage for the Bilibili Inc ADR (BILI) stock in a research note released on September 25, 2024 offered a Equal-Weight rating with a price target of $20. Barclays was of a view on August 23, 2024 that the stock is Overweight, while Nomura gave the stock Buy rating on August 22, 2024, issuing a price target of $18. Daiwa Securities on their part issued Outperform rating on August 22, 2024.
